Drug intelligence / Profile preview

blattella germanica allergenic extract

Development stage
Phase 2
Lead developer
National Institute of Allergy and Infectious Diseases
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intranasal, Sublingual, Intradermal
01

Overview

Blattella germanica allergenic extract is a biological product derived from the German cockroach, used for both diagnosing and treating cockroach allergies. As a diagnostic, it is used in skin prick tests and nasal allergen challenges (NAC) to confirm sensitization. As a therapeutic, it is being investigated as an allergen-specific immunotherapy, primarily through subcutaneous injections (SCIT), to treat allergic conditions like asthma and perennial allergic rhinitis, particularly in urban children. The extract contains multiple allergens, including the major allergens Bla g 1 and Bla g 2, which trigger IgE-mediated responses in sensitized individuals. The goal of immunotherapy with this extract is to induce immune tolerance by modulating the body's response, which involves shifting from a Th2-driven allergic reaction to a more tolerant state, characterized by the production of blocking IgG antibodies and a reduction in inflammatory cytokines. The National Institute of Allergy and Infectious Diseases (NIAID) and the Inner City Asthma Consortium (ICAC) have sponsored several clinical trials to evaluate its efficacy and safety.

Other names
German cockroach allergenic extractcockroach extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on blattella germanica allergenic extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on blattella germanica allergenic extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call